Showing 1 - 6 results of 6 for search 'Yasumasa Takii', query time: 0.03s Refine Results
  1. 1
    The first case of rectal myxoid liposarcoma identified by FUS-DDIT3 fusion, presenting as a submucosal tumor with erosion

    The first case of rectal myxoid liposarcoma identified by FUS-DDIT3 fusion, presenting as a submucosal tumor with erosion by Hiroshi Kono, Yoshitane Tsukamoto, Shohei Matsuo, Hideki Hashidate, Hiroyuki Shibuya, Takashi Kobayashi, Yasumasa Takii, Seiichi Hirota

    Published 2018-11-01
    Get full text
    Article
  2. 2
    A multicenter prospective observational study of lymph node metastasis patterns and short‐term outcomes of extended lymphadenectomy in right‐sided colon cancer

    A multicenter prospective observational study of lymph node metastasis patterns and short‐term outcomes of extended lymphadenectomy in right‐sided colon cancer by Shunsuke Tsukamoto, Akira Ouchi, Koji Komori, Manabu Shiozawa, Masayoshi Yasui, Masayuki Ohue, Hitoshi Nogami, Yasumasa Takii, Konosuke Moritani, Yukihide Kanemitsu

    Published 2023-11-01
    Get full text
    Article
  3. 3
    Response to Comment on: “Prognostic Relevance of Primary Tumor Sidedness in Early-Stage Colorectal Cancer: An Integrated Analysis of 4 Randomized Controlled Trials (JCOG2003A)”

    Response to Comment on: “Prognostic Relevance of Primary Tumor Sidedness in Early-Stage Colorectal Cancer: An Integrated Analysis of 4 Randomized Controlled Trials (JCOG2003A)” by Akira Ouchi, MD, PhD, Shunsuke Tsukamoto, MD, PhD, Atsuo Takashima, MD, PhD, Yasuhiro Shimada, MD, Tetsuya Hamaguchi, MD, PhD, Masafumi Inomata, MD, PhD, Yasumasa Takii, MD, Ryo Sadachi, PhD, Yukihide Kanemitsu, MD

    Published 2024-12-01
    Get full text
    Article
  4. 4
    Evaluation of a 55-gene classifier as a prognostic biomarker for adjuvant chemotherapy in stage III colon cancer patients

    Evaluation of a 55-gene classifier as a prognostic biomarker for adjuvant chemotherapy in stage III colon cancer patients by Eiji Oki, Eiji Shinto, Mototsugu Shimokawa, Shigeki Yamaguchi, Megumi Ishiguro, Seiji Hasegawa, Yasumasa Takii, Hideyuki Ishida, Tetsuya Kusumoto, Masaru Morita, Naohiro Tomita, Manabu Shiozawa, Masafumi Tanaka, Heita Ozawa, Yojiro Hashiguchi, Shinobu Ohnuma, Sachiyo Tada, Tomoko Matsushima, Kazuo Hase

    Published 2021-12-01
    Get full text
    Article
  5. 5
    Trial Protocol of a Phase II Study of mFOLFOXIRI after Metastasectomy in Patients with Oligometastatic Colorectal Cancer (FANTASTIC Study)

    Trial Protocol of a Phase II Study of mFOLFOXIRI after Metastasectomy in Patients with Oligometastatic Colorectal Cancer (FANTASTIC Study) by Kozo Kataoka, Takeshi Yamada, Kentaro Yamazaki, Keita Mori, Nobuhisa Matsuhashi, Manabu Shiozawa, Takuma Iwai, Masahiro Goto, Masayoshi Yasui, Yasumasa Takii, Takeshi Suto, Yasuyuki Takamizawa, Naoto Takase, Shruti Sharma, Joe Ensor, Adham Jurdi, Minetta C. Liu, Masataka Ikeda, Yukihide Kanemitsu

    Published 2024-07-01
    Get full text
    Article
  6. 6
    Impact of resection for ovarian metastases from colorectal cancer and clinicopathologic analysis: A multicenter retrospective study in Japan

    Impact of resection for ovarian metastases from colorectal cancer and clinicopathologic analysis: A multicenter retrospective study in Japan by Hiroyasu Kagawa, Yusuke Kinugasa, Tomohiro Yamaguchi, Masayuki Ohue, Kazushige Kawai, Junichiro Hiro, Seiichi Shinji, Hiroaki Nozawa, Yasumitsu Hirano, Koji Komori, Yasumasa Takii, Takeshi Suto, Shunsuke Tsukamoto, Yoshito Akagi, Heita Ozawa, Yuji Toiyama, Kazuhito Minami, Tomoharu Shimizu, Kay Uehara, Kazuhiro Sakamoto, Keita Mori, Kenichi Sugihara, Yoichi Ajioka

    Published 2024-03-01
    Get full text
    Article

Search Tools: